Latest News about NVO
Recent news which mentions NVO
From Motley Fool
From Benzinga
From Benzinga
Decoding Novo Nordisk's Options Activity: What's the Big Picture?
January 21, 2025
Tickers
NVO
From Benzinga
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
January 21, 2025
Tickers
NVO
From Motley Fool
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
From Benzinga
Is Novo Nordisk Stock a Buy?
January 18, 2025
From Motley Fool
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
January 17, 2025
From Motley Fool
5 Stocks to Buy Now for Big Returns in 2025
January 17, 2025
From Motley Fool
Novo Nordisk's Higher Dose Of Wegovy Shows Roughly 21% Weight Loss
January 17, 2025
From Benzinga
Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
January 17, 2025
From Motley Fool
Stocks Fail To Rise Despite Benign Producer Inflation, 30-Year Treasury Yields Hit 5%, Ely Lilly Tumbles: What's Driving Markets Tuesday?
January 14, 2025
From Benzinga
From Motley Fool
From Motley Fool
4 Top Dividend Growth Stocks to Build Your Portfolio Around in 2025
January 10, 2025
From Motley Fool
Best Healthcare Stock to Buy: Eli Lilly vs. Novo Nordisk
January 08, 2025
From Motley Fool
Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals
January 08, 2025
From Benzinga
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
January 08, 2025
From Motley Fool
From Benzinga
Novo Nordisk's Sponsorship Deals With UK Pharmacies Linked To Weight-Loss Drugs Raise Ethical Concerns
January 07, 2025
From Benzinga
Investors Look Back at 2024
January 06, 2025
From Motley Fool
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
From Benzinga
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
January 06, 2025
From Benzinga
Better Buy: Novo Nordisk vs. AstraZeneca
January 04, 2025
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.